{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:04:52Z","timestamp":1793851492705,"version":"4.6.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021YFA1100900, 2022YFA1103300"],"award-info":[{"award-number":["2021YFA1100900, 2022YFA1103300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Program of the National Natural Science Foundation of China","award":["82530009"],"award-info":[{"award-number":["82530009"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270229, 82570263"],"award-info":[{"award-number":["82270229, 82570263"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032579","name":"Beijing Medical Award Foundation","doi-asserted-by":"crossref","award":["YXJL-2024-0039-0055"],"award-info":[{"award-number":["YXJL-2024-0039-0055"]}],"id":[{"id":"10.13039\/100032579","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07998-2","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:24:35Z","timestamp":1773293075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The PI3K\u2013AKT pathway mediates the imbalance of bone marrow macrophage polarization in patients with immune thrombocytopenia"],"prefix":"10.1186","volume":"24","author":[{"given":"Meng-Zhu","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Xia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-2642","authenticated-orcid":false,"given":"Yuan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"10","key":"7998_CR1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1056\/NEJMcp1810479","volume":"381","author":"N Cooper","year":"2019","unstructured":"Cooper N, Ghanima W. Immune Thrombocytopenia. N Engl J Med. 2019;381(10):945\u201355.","journal-title":"N Engl J Med"},{"issue":"5","key":"7998_CR2","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1182\/blood.V81.5.1246.1246","volume":"81","author":"P Berchtold","year":"1993","unstructured":"Berchtold P, Wenger M. Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment. Blood. 1993;81(5):1246\u201350.","journal-title":"Blood"},{"issue":"26","key":"7998_CR3","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","volume":"113","author":"DB Cines","year":"2009","unstructured":"Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113(26):6511\u201321.","journal-title":"Blood"},{"issue":"4","key":"7998_CR4","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1182\/blood-2003-08-2672","volume":"103","author":"R McMillan","year":"2004","unstructured":"McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2004;103(4):1364\u20139.","journal-title":"Blood"},{"issue":"9","key":"7998_CR5","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/nm921","volume":"9","author":"B Olsson","year":"2003","unstructured":"Olsson B, Andersson PO, Jernas M, Jacobsson S, Carlsson B, Carlsson LM, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9(9):1123\u20134.","journal-title":"Nat Med"},{"issue":"11","key":"7998_CR6","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386\u201393.","journal-title":"Blood"},{"issue":"2","key":"7998_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/jcm6020016","volume":"6","author":"A Zufferey","year":"2017","unstructured":"Zufferey A, Kapur R, Semple JW. Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP). J Clin Med. 2017;6(2):16.","journal-title":"J Clin Med"},{"issue":"9","key":"7998_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1056\/NEJMoa030254","volume":"349","author":"Y Cheng","year":"2003","unstructured":"Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, et al. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. N Engl J Med. 2003;349(9):831\u20136.","journal-title":"N Engl J Med"},{"key":"7998_CR9","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.ejim.2016.09.001","volume":"37","author":"H Frederiksen","year":"2017","unstructured":"Frederiksen H, Ghanima W. Response of first line treatment with corticosteroids in a population-based cohort of adults with primary immune thrombocytopenia. Eur J Intern Med. 2017;37:e23\u20135.","journal-title":"Eur J Intern Med"},{"issue":"12","key":"7998_CR10","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1182\/blood-2016-03-603365","volume":"128","author":"A Cuker","year":"2016","unstructured":"Cuker A, Neunert CE. How I treat refractory immune thrombocytopenia. Blood. 2016;128(12):1547\u201354.","journal-title":"Blood"},{"issue":"2","key":"7998_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","volume":"115","author":"D Provan","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115(2):168\u201386.","journal-title":"Blood"},{"issue":"16","key":"7998_CR12","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","volume":"117","author":"C Neunert","year":"2011","unstructured":"Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr., Crowther MA, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16):4190\u2013207.","journal-title":"Blood"},{"issue":"5","key":"7998_CR13","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1182\/blood-2011-12-309153","volume":"120","author":"W Ghanima","year":"2012","unstructured":"Ghanima W, Godeau B, Cines DB, Bussel JB. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood. 2012;120(5):960\u20139.","journal-title":"Blood"},{"issue":"11","key":"7998_CR14","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1182\/blood-2017-09-807248","volume":"131","author":"Y Kong","year":"2018","unstructured":"Kong Y, Cao XN, Zhang XH, Shi MM, Lai YY, Wang Y, et al. Atorvastatin enhances bone marrow endothelial cell function in corticosteroid-resistant immune thrombocytopenia patients. Blood. 2018;131(11):1219\u201333.","journal-title":"Blood"},{"issue":"6","key":"7998_CR15","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00277-016-2641-y","volume":"95","author":"Y Song","year":"2016","unstructured":"Song Y, Wang YT, Huang XJ, Kong Y. Abnormalities of the bone marrow immune microenvironment in patients with immune thrombocytopenia. Ann Hematol. 2016;95(6):959\u201365.","journal-title":"Ann Hematol"},{"issue":"23","key":"7998_CR16","doi-asserted-by":"publisher","first-page":"4815","DOI":"10.1182\/blood-2009-11-253534","volume":"116","author":"IG Winkler","year":"2010","unstructured":"Winkler IG, Sims NA, Pettit AR, Barbier V, Nowlan B, Helwani F, et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood. 2010;116(23):4815\u201328.","journal-title":"Blood"},{"issue":"11","key":"7998_CR17","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/ni.2408","volume":"13","author":"A Ludin","year":"2012","unstructured":"Ludin A, Itkin T, Gur-Cohen S, Mildner A, Shezen E, Golan K, et al. Monocytes-macrophages that express alpha-smooth muscle actin preserve primitive hematopoietic cells in the bone marrow. Nat Immunol. 2012;13(11):1072\u201382.","journal-title":"Nat Immunol"},{"issue":"4","key":"7998_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.stem.2016.01.013","volume":"18","author":"J Hur","year":"2016","unstructured":"Hur J, Choi JI, Lee H, Nham P, Kim TW, Chae CW, et al. CD82\/KAI1 Maintains the Dormancy of Long-Term Hematopoietic Stem Cells through Interaction with DARC-Expressing Macrophages. Cell Stem Cell. 2016;18(4):508\u201321.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"7998_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1084\/jem.20101688","volume":"208","author":"A Chow","year":"2011","unstructured":"Chow A, Lucas D, Hidalgo A, Mendez-Ferrer S, Hashimoto D, Scheiermann C, et al. Bone marrow CD169\u2009+\u2009macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med. 2011;208(2):261\u201371.","journal-title":"J Exp Med"},{"issue":"3","key":"7998_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/ajh.2830440312","volume":"44","author":"N Saito","year":"1993","unstructured":"Saito N, Takemori N, Hirai K, Onodera R, Watanabe S, Namiki M. Macrophage-megakaryocyte interaction in bone marrow after high-dose intravenous immunoglobulin therapy. Am J Hematol. 1993;44(3):201\u20133.","journal-title":"Am J Hematol"},{"issue":"8","key":"7998_CR21","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1182\/blood.V96.8.2834","volume":"96","author":"F Alves-Rosa","year":"2000","unstructured":"Alves-Rosa F, Stanganelli C, Cabrera J, van Rooijen N, Palermo MS, Isturiz MA. Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model. Blood. 2000;96(8):2834\u201340.","journal-title":"Blood"},{"issue":"1","key":"7998_CR22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1046\/j.1365-2141.2003.04259.x","volume":"121","author":"F Alves-Rosa","year":"2003","unstructured":"Alves-Rosa F, Vermeulen M, Cabrera J, Stanganelli C, Capozzo A, Narbaitz M, et al. Macrophage depletion following liposomal-encapsulated clodronate (LIP-CLOD) injection enhances megakaryocytopoietic and thrombopoietic activities in mice. Br J Haematol. 2003;121(1):130\u20138.","journal-title":"Br J Haematol"},{"issue":"12","key":"7998_CR23","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1172\/JCI26891","volume":"115","author":"SR Patel","year":"2005","unstructured":"Patel SR, Hartwig JH, Italiano JE. Jr. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest. 2005;115(12):3348\u201354.","journal-title":"J Clin Invest"},{"issue":"1","key":"7998_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nm973","volume":"10","author":"ST Avecilla","year":"2004","unstructured":"Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med. 2004;10(1):64\u201371.","journal-title":"Nat Med"},{"issue":"1","key":"7998_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tmrv.2009.09.003","volume":"24","author":"JA Reems","year":"2010","unstructured":"Reems JA, Pineault N, Sun S. In vitro megakaryocyte production and platelet biogenesis: state of the art. Transfus Med Rev. 2010;24(1):33\u201343.","journal-title":"Transfus Med Rev"},{"issue":"4","key":"7998_CR26","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1182\/blood-2002-03-0686","volume":"100","author":"S De Botton","year":"2002","unstructured":"De Botton S, Sabri S, Daugas E, Zermati Y, Guidotti JE, Hermine O, et al. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood. 2002;100(4):1310\u20137.","journal-title":"Blood"},{"issue":"5","key":"7998_CR27","first-page":"753","volume":"178","author":"W Vainchenker","year":"1994","unstructured":"Vainchenker W, Debili N, Methia N, Mouthon MA, Wendling F. [Hematopoiesis and its regulation. Comparison between erythropoiesis and megakaryocytopoiesis]. Bull Acad Natl Med. 1994;178(5):753\u201378. discussion 78\u2009\u2013\u20099.","journal-title":"Bull Acad Natl Med"},{"issue":"1","key":"7998_CR28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-021-00627-y","volume":"6","author":"HY Zhao","year":"2021","unstructured":"Zhao HY, Zhang YY, Xing T, Tang SQ, Wen Q, Lyu ZS, et al. M2 macrophages, but not M1 macrophages, support megakaryopoiesis by upregulating PI3K-AKT pathway activity. Signal Transduct Target Ther. 2021;6(1):234.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"7998_CR29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/bjh.15452","volume":"182","author":"HY Zhao","year":"2018","unstructured":"Zhao HY, Lyu ZS, Duan CW, Song Y, Han TT, Mo XD, et al. An unbalanced monocyte macrophage polarization in the bone marrow microenvironment of patients with poor graft function after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2018;182(5):679\u201392.","journal-title":"Br J Haematol"},{"issue":"1","key":"7998_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12967-023-04061-2","volume":"21","author":"Y Huo","year":"2023","unstructured":"Huo Y, Zhang H, Sa L, Zheng W, He Y, Lyu H, et al. M1 polarization enhances the antitumor activity of chimeric antigen receptor macrophages in solid tumors. J Transl Med. 2023;21(1):225.","journal-title":"J Transl Med"},{"issue":"1","key":"7998_CR31","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1186\/s12967-025-06556-6","volume":"23","author":"Y Qi","year":"2025","unstructured":"Qi Y, Sun D, Zhai X, Chen F, Niu J, Zhu H. Macrophages in the premetastatic and metastatic niche: key functions and therapeutic directions. J Transl Med. 2025;23(1):602.","journal-title":"J Transl Med"},{"issue":"3","key":"7998_CR32","doi-asserted-by":"publisher","first-page":"100152","DOI":"10.59717\/j.xinn-med.2025.100152","volume":"3","author":"H Lu","year":"2025","unstructured":"Lu H, Wang Y, Mo X, Hu X. Balancing cGVHD and GVL with Axatilimab: A macrophage-targeted strategy in allogeneic transplantation. Innov Med. 2025;3(3):100152.","journal-title":"Innov Med"},{"issue":"5","key":"7998_CR33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.it.2012.11.001","volume":"34","author":"LB Ivashkiv","year":"2013","unstructured":"Ivashkiv LB. Epigenetic regulation of macrophage polarization and function. Trends Immunol. 2013;34(5):216\u201323.","journal-title":"Trends Immunol"},{"issue":"1","key":"7998_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14\u201320.","journal-title":"Immunity"},{"issue":"9","key":"7998_CR35","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1111\/jth.13767","volume":"15","author":"Q Feng","year":"2017","unstructured":"Feng Q, Xu M, Yu YY, Hou Y, Mi X, Sun YX, et al. High-dose dexamethasone or all-trans\u2010retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia. J Thromb Haemost. 2017;15(9):1845\u201358.","journal-title":"J Thromb Haemost"},{"issue":"16","key":"7998_CR36","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1097\/CM9.0000000000003586","volume":"138","author":"Q Liu","year":"2025","unstructured":"Liu Q, Liu A, Leng S, Zhang X, Wang X, Cheng Z, et al. Itaconate derivative 4-OI inhibits M1 macrophage polarization and restores its impaired function in immune thrombocytopenia through metabolic reprogramming. Chin Med J. 2025;138(16):2006\u201315.","journal-title":"Chin Med J"},{"issue":"6","key":"7998_CR37","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41375-024-02219-5","volume":"38","author":"K Behrens","year":"2024","unstructured":"Behrens K, Kauppi M, Viney EM, Kueh AJ, Hyland CD, Willson TA, et al. Differential in vivo roles of Mpl cytoplasmic tyrosine residues in murine hematopoiesis and myeloproliferative disease. Leukemia. 2024;38(6):1342\u201352.","journal-title":"Leukemia"},{"issue":"19","key":"7998_CR38","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1016\/j.cell.2023.07.037","volume":"186","author":"N Tsutsumi","year":"2023","unstructured":"Tsutsumi N, Masoumi Z, James SC, Tucker JA, Winkelmann H, Grey W, et al. Structure of the thrombopoietin-MPL receptor complex is a blueprint for biasing hematopoiesis. Cell. 2023;186(19):4189\u2013203. e22.","journal-title":"Cell"},{"issue":"19","key":"7998_CR39","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1056\/NEJMra052706","volume":"354","author":"K Kaushansky","year":"2006","unstructured":"Kaushansky K. Lineage-specific hematopoietic growth factors. N Engl J Med. 2006;354(19):2034\u201345.","journal-title":"N Engl J Med"},{"issue":"2","key":"7998_CR40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/bjh.12781","volume":"165","author":"DJ Kuter","year":"2014","unstructured":"Kuter DJ. Milestones in understanding platelet production: a historical overview. Br J Haematol. 2014;165(2):248\u201358.","journal-title":"Br J Haematol"},{"issue":"5177","key":"7998_CR41","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1126\/science.8073287","volume":"265","author":"AL Gurney","year":"1994","unstructured":"Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW. Thrombocytopenia in c-mpl-deficient mice. Science. 1994;265(5177):1445\u20137.","journal-title":"Science"},{"issue":"2","key":"7998_CR42","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1084\/jem.183.2.651","volume":"183","author":"FJ de Sauvage","year":"1996","unstructured":"de Sauvage FJ, Carver-Moore K, Luoh SM, Ryan A, Dowd M, Eaton DL, et al. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med. 1996;183(2):651\u20136.","journal-title":"J Exp Med"},{"issue":"1","key":"7998_CR43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12185-013-1382-0","volume":"98","author":"DJ Kuter","year":"2013","unstructured":"Kuter DJ. The biology of thrombopoietin and thrombopoietin receptor agonists. Int J Hematol. 2013;98(1):10\u201323.","journal-title":"Int J Hematol"},{"issue":"16","key":"7998_CR44","doi-asserted-by":"publisher","first-page":"12665","DOI":"10.3390\/ijms241612665","volume":"24","author":"A Tsay","year":"2023","unstructured":"Tsay A, Wang J-C. The Role of PIK3R1 in Metabolic Function and Insulin Sensitivity. Int J Mol Sci. 2023;24(16):12665.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"7998_CR45","doi-asserted-by":"publisher","first-page":"e70236","DOI":"10.1002\/iid3.70236","volume":"13","author":"Y Chen","year":"2025","unstructured":"Chen Y, Shi Y, Sun Y, Peng Y, Shi G, Liu Y, et al. Characteristics of Corticosteroid-Resistant Secondary Immune Thrombocytopenia Associated With Connective Tissue Diseases in China: A Retrospective Comparative Study. Immun Inflamm Dis. 2025;13(7):e70236.","journal-title":"Immun Inflamm Dis"},{"issue":"23","key":"7998_CR46","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829\u201366.","journal-title":"Blood Adv"},{"issue":"3","key":"7998_CR47","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1182\/blood.2021013393","volume":"139","author":"YJ Wu","year":"2022","unstructured":"Wu YJ, Liu H, Zeng QZ, Liu Y, Wang JW, Wang WS, et al. All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP. Blood. 2022;139(3):333\u201342.","journal-title":"Blood"},{"issue":"2","key":"7998_CR48","doi-asserted-by":"publisher","first-page":"e31129","DOI":"10.1002\/jcp.31129","volume":"239","author":"T Xing","year":"2024","unstructured":"Xing T, Yao WL, Zhao HY, Wang J, Zhang YY, Lv M, et al. Bone marrow macrophages are involved in the ineffective hematopoiesis of myelodysplastic syndromes. J Cell Physiol. 2024;239(2):e31129.","journal-title":"J Cell Physiol"},{"key":"7998_CR49","doi-asserted-by":"publisher","first-page":"216937","DOI":"10.1016\/j.canlet.2024.216937","volume":"592","author":"M Liang","year":"2024","unstructured":"Liang M, Lyu ZS, Zhang YY, Tang SQ, Xing T, Chen YH, et al. Activation of PPAR\u03b4 in bone marrow endothelial progenitor cells improves their hematopoiesis-supporting ability after myelosuppressive injury. Cancer Lett. 2024;592:216937.","journal-title":"Cancer Lett"},{"key":"7998_CR50","doi-asserted-by":"publisher","first-page":"102677","DOI":"10.1016\/j.ebiom.2020.102677","volume":"53","author":"ZS Lyu","year":"2020","unstructured":"Lyu ZS, Cao XN, Wen Q, Mo XD, Zhao HY, Chen YH, et al. Autophagy in endothelial cells regulates their haematopoiesis-supporting ability. EBioMedicine. 2020;53:102677.","journal-title":"EBioMedicine"},{"issue":"10","key":"7998_CR51","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.3324\/haematol.2021.279756","volume":"107","author":"ZS Lyu","year":"2022","unstructured":"Lyu ZS, Tang SQ, Xing T, Zhou Y, Lv M, Fu HX, et al. The glycolytic enzyme PFKFB3 determines bone marrow endothelial progenitor cell damage after chemotherapy and irradiation. Haematologica. 2022;107(10):2365\u201380.","journal-title":"Haematologica"},{"issue":"25","key":"7998_CR52","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1182\/blood-2016-03-702803","volume":"128","author":"MM Shi","year":"2016","unstructured":"Shi MM, Kong Y, Song Y, Sun YQ, Wang Y, Zhang XH, et al. Atorvastatin enhances endothelial cell function in posttransplant poor graft function. Blood. 2016;128(25):2988\u201399.","journal-title":"Blood"},{"issue":"20","key":"7998_CR53","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1182\/blood-2010-02-267435","volume":"116","author":"L Yang","year":"2010","unstructured":"Yang L, Wang L, Zhao CH, Zhu XJ, Hou Y, Jun P, et al. Contributions of TRAIL-mediated megakaryocyte apoptosis to impaired megakaryocyte and platelet production in immune thrombocytopenia. Blood. 2010;116(20):4307\u201316.","journal-title":"Blood"},{"issue":"7","key":"7998_CR54","doi-asserted-by":"publisher","first-page":"e0001721","DOI":"10.1128\/AAC.00017-21","volume":"65","author":"EV Troth","year":"2021","unstructured":"Troth EV, Kyle DE. EdU Incorporation To Assess Cell Proliferation and Drug Susceptibility in Naegleria fowleri. Antimicrob Agents Chemother. 2021;65(7):e0001721.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"7998_CR55","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang D, Chen M, Huang X, Zhang G, Zeng L, Zhang G, et al. SRplot: A free online platform for data visualization and graphing. PLoS ONE. 2023;18(11):e0294236.","journal-title":"PLoS ONE"},{"issue":"1","key":"7998_CR56","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1186\/s12967-024-05900-6","volume":"22","author":"Z Huang","year":"2024","unstructured":"Huang Z, Iqbal Z, Zhao Z, Liu J, Alabsi AM, Shabbir M, et al. Cellular crosstalk in the bone marrow niche. J Transl Med. 2024;22(1):1096.","journal-title":"J Transl Med"},{"key":"7998_CR57","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3389\/fimmu.2020.01499","volume":"11","author":"AN Seyfried","year":"2020","unstructured":"Seyfried AN, Maloney JM, MacNamara KC. Macrophages Orchestrate Hematopoietic Programs and Regulate HSC Function During Inflammatory Stress. Front Immunol. 2020;11:1499.","journal-title":"Front Immunol"},{"issue":"8","key":"7998_CR58","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1182\/bloodadvances.2018015685","volume":"2","author":"Y Luo","year":"2018","unstructured":"Luo Y, Shao L, Chang J, Feng W, Liu YL, Cottler-Fox MH, et al. M1 and M2 macrophages differentially regulate hematopoietic stem cell self-renewal and ex vivo expansion. Blood Adv. 2018;2(8):859\u201370.","journal-title":"Blood Adv"},{"issue":"2","key":"7998_CR59","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/bmt.2015.229","volume":"51","author":"Y Kong","year":"2016","unstructured":"Kong Y, Wang YT, Hu Y, Han W, Chang YJ, Zhang XH, et al. The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function. Bone Marrow Transpl. 2016;51(2):249\u201355.","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"7998_CR60","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1186\/s12967-025-07075-0","volume":"23","author":"L Cao","year":"2025","unstructured":"Cao L, Ding L, Xia Q, Zhang Z, Li M, Song S, et al. Macrophage polarization in diabetic vascular complications: mechanistic insights and therapeutic targets. J Transl Med. 2025;23(1):1050.","journal-title":"J Transl Med"},{"issue":"7","key":"7998_CR61","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1182\/blood-2003-07-2268","volume":"103","author":"FP Panitsas","year":"2004","unstructured":"Panitsas FP, Theodoropoulou M, Kouraklis A, Karakantza M, Theodorou GL, Zoumbos NC, et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood. 2004;103(7):2645\u20137.","journal-title":"Blood"},{"issue":"19","key":"7998_CR62","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.4161\/cc.21572","volume":"11","author":"TD Troutman","year":"2012","unstructured":"Troutman TD, Bazan JF, Pasare C. Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K. Cell Cycle. 2012;11(19):3559\u201367.","journal-title":"Cell Cycle"},{"issue":"6","key":"7998_CR63","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.ymthe.2021.02.006","volume":"29","author":"C Yang","year":"2021","unstructured":"Yang C, Dou R, Wei C, Liu K, Shi D, Zhang C, et al. Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis. Mol Ther. 2021;29(6):2088\u2013107.","journal-title":"Mol Ther"},{"issue":"11","key":"7998_CR64","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1111\/cas.14616","volume":"111","author":"Q Luo","year":"2020","unstructured":"Luo Q, Zheng N, Jiang L, Wang T, Zhang P, Liu Y, et al. Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer. Cancer Sci. 2020;111(11):4000\u201311.","journal-title":"Cancer Sci"},{"key":"7998_CR65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jconrel.2020.02.011","volume":"321","author":"M Li","year":"2020","unstructured":"Li M, Li M, Yang Y, Liu Y, Xie H, Yu Q, et al. Remodeling tumor immune microenvironment via targeted blockade of PI3K-gamma and CSF-1\/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy. J Control Release. 2020;321:23\u201335.","journal-title":"J Control Release"},{"issue":"1","key":"7998_CR66","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1186\/s12967-024-05901-5","volume":"22","author":"S Dai","year":"2024","unstructured":"Dai S, Zhuang H, Li Z, Chen Z, Chai Y, Zhou Q. miR-122\/NEGR1 axis contributes colorectal cancer liver metastasis by PI3K\/AKT pathway and macrophage modulation. J Transl Med. 2024;22(1):1060.","journal-title":"J Transl Med"},{"issue":"6","key":"7998_CR67","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.4049\/jimmunol.180.6.4218","volume":"180","author":"JP Luyendyk","year":"2008","unstructured":"Luyendyk JP, Schabbauer GA, Tencati M, Holscher T, Pawlinski R, Mackman N. Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes\/macrophages. J Immunol. 2008;180(6):4218\u201326.","journal-title":"J Immunol"},{"issue":"11","key":"7998_CR68","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2012-02-408252","volume":"120","author":"D Ruckerl","year":"2012","unstructured":"Ruckerl D, Jenkins SJ, Laqtom NN, Gallagher IJ, Sutherland TE, Duncan S, et al. Induction of IL-4Ralpha-dependent microRNAs identifies PI3K\/Akt signaling as essential for IL-4-driven murine macrophage proliferation in vivo. Blood. 2012;120(11):2307\u201316.","journal-title":"Blood"},{"issue":"6481","key":"7998_CR69","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/369533a0","volume":"369","author":"FJ De Sauvage","year":"1994","unstructured":"De Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 1994;369(6481):533\u20138.","journal-title":"Nature"},{"issue":"6481","key":"7998_CR70","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/369568a0","volume":"369","author":"K Kaushansky","year":"1994","unstructured":"Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 1994;369(6481):568\u201371.","journal-title":"Nature"},{"issue":"1","key":"7998_CR71","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1006\/bbrc.1995.2768","volume":"217","author":"M Yamada","year":"1995","unstructured":"Yamada M, Komatsu N, Okada K, Kato T, Miyazaki H, Miura Y. Thrombopoietin induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in a human thrombopoietin-dependent cell line. Biochem Biophys Res Commun. 1995;217(1):230\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"7998_CR72","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1182\/blood.V89.2.483","volume":"89","author":"JG Drachman","year":"1997","unstructured":"Drachman JG, Sabath DF, Fox NE, Kaushansky K. Thrombopoietin signal transduction in purified murine megakaryocytes. Blood. 1997;89(2):483\u201392.","journal-title":"Blood"},{"issue":"2","key":"7998_CR73","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4161\/cc.7.2.5148","volume":"7","author":"T Nakao","year":"2008","unstructured":"Nakao T, Geddis AE, Fox NE, Kaushansky K. PI3K\/Akt\/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27Kip1. Cell Cycle. 2008;7(2):257\u201366.","journal-title":"Cell Cycle"},{"issue":"1","key":"7998_CR74","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1182\/blood.V97.1.139","volume":"97","author":"M Ballmaier","year":"2001","unstructured":"Ballmaier M, Germeshausen M, Schulze H, Cherkaoui K, Lang S, Gaudig A, et al. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood. 2001;97(1):139\u201346.","journal-title":"Blood"},{"issue":"3","key":"7998_CR75","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1172\/JCI0215430","volume":"110","author":"N Fox","year":"2002","unstructured":"Fox N, Priestley G, Papayannopoulou T, Kaushansky K. Thrombopoietin expands hematopoietic stem cells after transplantation. J Clin Invest. 2002;110(3):389\u201394.","journal-title":"J Clin Invest"},{"key":"7998_CR76","doi-asserted-by":"crossref","unstructured":"Chen Y, Sun T, Gao D, Wang W, Zhou Z, Gao G, et al. Dose-optimised recombinant human thrombopoietin\u2009<em>versus<\/em> eltrombopag in patients with immune thrombocytopenia: a multicenter, randomised controlled trial (The TE-ITP Study). eClinicalMedicine. 2025;87.","DOI":"10.1016\/j.eclinm.2025.103459"},{"issue":"10","key":"7998_CR77","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1182\/blood-2014-06-581868","volume":"125","author":"H Zhou","year":"2015","unstructured":"Zhou H, Xu M, Qin P, Zhang H-y, Yuan C-l, Zhao H-g, et al. A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP. Blood. 2015;125(10):1541\u20137.","journal-title":"Blood"},{"issue":"12","key":"7998_CR78","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1002\/ajh.25989","volume":"95","author":"Y Yu","year":"2020","unstructured":"Yu Y, Wang M, Hou Y, Qin P, Zeng Q, Yu W, et al. High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial. Am J Hematol. 2020;95(12):1542\u201352.","journal-title":"Am J Hematol"},{"issue":"1","key":"7998_CR79","doi-asserted-by":"publisher","first-page":"9000","DOI":"10.1038\/s41467-024-52942-x","volume":"15","author":"DK Deochand","year":"2024","unstructured":"Deochand DK, Dacic M, Bale MJ, Daman AW, Chaudhary V, Josefowicz SZ, et al. Mechanisms of epigenomic and functional convergence between glucocorticoid- and IL4-driven macrophage programming. Nat Commun. 2024;15(1):9000.","journal-title":"Nat Commun"},{"key":"7998_CR80","doi-asserted-by":"crossref","unstructured":"Li CY, Chen DD, Zhang XY, Tang SQ, Shen MZ, Yu YT, et al. Hematopoiesis could be improved by correcting aberrant bone marrow macrophages polarization in aplastic anemia patients. Sci China Life Sci. 2026.","DOI":"10.1007\/s11427-025-3194-y"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07998-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07998-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07998-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T10:02:43Z","timestamp":1776679363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07998-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7998"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07998-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethics committee review board of Peking University People\u2019s Hospital, and written informed consent was obtained from the subjects in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"548"}}